KIEU NGUYEN: Open Payments
NPI 1386186161 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$683 in 42 payments from 16 companies in 2025. Trend: 2023 $533 · 2024 $612 · 2025 $683
Food & beverage: $683
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $180 |
| ABBVIE INC. | 14 | $151 |
| AstraZeneca Pharmaceuticals LP | 3 | $52 |
| SANOFI-AVENTIS U.S. LLC | 2 | $42 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $33 |
| Soleno Therapeutics, Inc. | 1 | $30 |
| Corcept Therapeutics | 1 | $26 |
| Lilly USA, LLC | 1 | $25 |
| Seqirus USA Inc | 1 | $22 |
| Novartis Pharmaceuticals Corporation | 1 | $21 |
Products named: Wegovy, QULIPTA, AIRSUPRA, UBRELVY, TZIELD, JARDIANCE, VYKAT XR, Korlym.
Industry payments across TX — which companies pay providers there.
